Centene Corp. (CNC) Stock Competitors & Peer Comparison
See (CNC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNC | $65.73 | +1.48% | 32.5B | -5.00 | -$13.14 | N/A |
| UNH | $427.89 | +2.97% | 388.4B | 26.18 | $16.34 | +2.11% |
| CVS | $104.34 | -0.31% | 133.1B | 45.75 | $2.28 | +2.56% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $395.18 | +2.03% | 85.9B | 12.85 | $30.78 | +1.76% |
| CI | $282.79 | +0.33% | 74.7B | 9.14 | $30.90 | +2.17% |
| HUM | $383.84 | +2.09% | 46.1B | 24.21 | $15.86 | +0.93% |
| MOH | $229.74 | +6.34% | 12B | 33.16 | $6.92 | N/A |
| OSCR | $29.79 | +3.91% | 7.7B | -50.51 | -$0.59 | N/A |
| ALHC | $23.19 | +2.11% | 4.8B | 257.67 | $0.09 | N/A |
Stock Comparison
CNC vs UNH Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, UNH has a market cap of 388.4B. Regarding current trading prices, CNC is priced at $65.73, while UNH trades at $427.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas UNH's P/E ratio is 26.18. In terms of profitability, CNC's ROE is -0.29%, compared to UNH's ROE of +0.12%. Regarding short-term risk, CNC is less volatile compared to UNH. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check UNH's competition here
CNC vs CVS Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, CVS has a market cap of 133.1B. Regarding current trading prices, CNC is priced at $65.73, while CVS trades at $104.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas CVS's P/E ratio is 45.75. In terms of profitability, CNC's ROE is -0.29%, compared to CVS's ROE of +0.04%. Regarding short-term risk, CNC is less volatile compared to CVS. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check CVS's competition here
CNC vs ANTM Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, CNC is priced at $65.73, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas ANTM's P/E ratio is 18.99. In terms of profitability, CNC's ROE is -0.29%, compared to ANTM's ROE of +0.12%. Regarding short-term risk, CNC is less volatile compared to ANTM. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check ANTM's competition here
CNC vs ELV Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, ELV has a market cap of 85.9B. Regarding current trading prices, CNC is priced at $65.73, while ELV trades at $395.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas ELV's P/E ratio is 12.85. In terms of profitability, CNC's ROE is -0.29%, compared to ELV's ROE of +0.12%. Regarding short-term risk, CNC is less volatile compared to ELV. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check ELV's competition here
CNC vs CI Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, CI has a market cap of 74.7B. Regarding current trading prices, CNC is priced at $65.73, while CI trades at $282.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas CI's P/E ratio is 9.14. In terms of profitability, CNC's ROE is -0.29%, compared to CI's ROE of +0.15%. Regarding short-term risk, CNC is less volatile compared to CI. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check CI's competition here
CNC vs HUM Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, HUM has a market cap of 46.1B. Regarding current trading prices, CNC is priced at $65.73, while HUM trades at $383.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas HUM's P/E ratio is 24.21. In terms of profitability, CNC's ROE is -0.29%, compared to HUM's ROE of +0.06%. Regarding short-term risk, CNC is less volatile compared to HUM. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check HUM's competition here
CNC vs MOH Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, MOH has a market cap of 12B. Regarding current trading prices, CNC is priced at $65.73, while MOH trades at $229.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas MOH's P/E ratio is 33.16. In terms of profitability, CNC's ROE is -0.29%, compared to MOH's ROE of +0.04%. Regarding short-term risk, CNC is less volatile compared to MOH. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check MOH's competition here
CNC vs OSCR Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, OSCR has a market cap of 7.7B. Regarding current trading prices, CNC is priced at $65.73, while OSCR trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas OSCR's P/E ratio is -50.51. In terms of profitability, CNC's ROE is -0.29%, compared to OSCR's ROE of -0.03%. Regarding short-term risk, CNC is less volatile compared to OSCR. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check OSCR's competition here
CNC vs ALHC Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, ALHC has a market cap of 4.8B. Regarding current trading prices, CNC is priced at $65.73, while ALHC trades at $23.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas ALHC's P/E ratio is 257.67. In terms of profitability, CNC's ROE is -0.29%, compared to ALHC's ROE of +0.11%. Regarding short-term risk, CNC is less volatile compared to ALHC. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check ALHC's competition here
CNC vs CLOV Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, CLOV has a market cap of 2.8B. Regarding current trading prices, CNC is priced at $65.73, while CLOV trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas CLOV's P/E ratio is -45.08. In terms of profitability, CNC's ROE is -0.29%, compared to CLOV's ROE of -0.17%. Regarding short-term risk, CNC is less volatile compared to CLOV. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check CLOV's competition here
CNC vs BHG Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, CNC is priced at $65.73, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas BHG's P/E ratio is -0.12. In terms of profitability, CNC's ROE is -0.29%, compared to BHG's ROE of -0.70%. Regarding short-term risk, CNC is less volatile compared to BHG. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check BHG's competition here
CNC vs CABR Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, CABR has a market cap of 17.8M. Regarding current trading prices, CNC is priced at $65.73, while CABR trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas CABR's P/E ratio is -4.17. In terms of profitability, CNC's ROE is -0.29%, compared to CABR's ROE of -3.00%. Regarding short-term risk, CNC is less volatile compared to CABR. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check CABR's competition here
CNC vs BMGL Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, BMGL has a market cap of 10.8M. Regarding current trading prices, CNC is priced at $65.73, while BMGL trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas BMGL's P/E ratio is -1.30. In terms of profitability, CNC's ROE is -0.29%, compared to BMGL's ROE of -1.95%. Regarding short-term risk, CNC is less volatile compared to BMGL. This indicates potentially lower risk in terms of short-term price fluctuations for CNC.Check BMGL's competition here
CNC vs AET Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, AET has a market cap of 0. Regarding current trading prices, CNC is priced at $65.73, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas AET's P/E ratio is N/A. In terms of profitability, CNC's ROE is -0.29%, compared to AET's ROE of +0.11%. Regarding short-term risk, CNC is more volatile compared to AET. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check AET's competition here
CNC vs GTS Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, GTS has a market cap of 0. Regarding current trading prices, CNC is priced at $65.73, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas GTS's P/E ratio is 10.41. In terms of profitability, CNC's ROE is -0.29%, compared to GTS's ROE of +0.07%. Regarding short-term risk, CNC is more volatile compared to GTS. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check GTS's competition here
CNC vs MGLN Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, CNC is priced at $65.73, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas MGLN's P/E ratio is 8.49. In terms of profitability, CNC's ROE is -0.29%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, CNC is more volatile compared to MGLN. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check MGLN's competition here
CNC vs UAM Comparison July 2026
CNC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNC stands at 32.5B. In comparison, UAM has a market cap of 0. Regarding current trading prices, CNC is priced at $65.73, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNC currently has a P/E ratio of -5.00, whereas UAM's P/E ratio is N/A. In terms of profitability, CNC's ROE is -0.29%, compared to UAM's ROE of +0.17%. Regarding short-term risk, CNC is more volatile compared to UAM. This indicates potentially higher risk in terms of short-term price fluctuations for CNC.Check UAM's competition here